Interferon (Intron A, Roferon-A, Actimmune (gamma interferon))

Description

Interferon is a cytokine-based immunotherapy agent that was evaluated as adjuvant treatment in resected colon cancer and for metastatic colorectal carcinoma. This biologic response modifier enhances the body's natural immune response against cancer cells through activation of immune effector cells and modulation of tumor cell growth. Based on the clinical trial data, both standard interferon and gamma interferon formulations have been tested in colorectal cancer treatment protocols, though with limited success compared to modern immunotherapies.

Mechanism of Action

Interferon binds to specific interferon receptors on cell surfaces, triggering intracellular signaling cascades through the JAK-STAT pathway that leads to enhanced immune cell activation and increased expression of immune response genes. The cytokine also directly inhibits tumor cell proliferation and enhances the presentation of tumor antigens to T-cells, promoting a more robust anti-tumor immune response.

Molecular Targets

Side Effects

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials